Alpha Growth PLC - Director/PDMR Shareholding
Alpha Growth plc
("Alpha" or the "Company")
Director / PDMR Dealing
Alpha Growth Plc (LSE: ALGW and OTCQB: ALPGF), a leading financial services company in the life insurance linked asset/wealth management business, is pleased to announce that the Company has been notified that the Directors of the Company named below have purchased ordinary shares of 0.1p each in the Company ("Shares") as listed below. The resulting interests of each of the Directors named below in the ordinary shares of the Company are also listed below.
|
Name |
Shares in Alpha before purchase |
Shares in Alpha purchased |
Resulting number of Shares held |
% of total shares in issue |
|
|
7,045,834 |
7,169,791 |
14,215,625 |
3.04 |
|
|
3,398,639 |
7,169,791 |
10,568,430 |
2.26 |
Notification and public disclosure of transactions by persons discharging managerial responsibilities.
|
1. |
Details of the person discharging managerial responsibilities/person closely associated |
|||||||
|
a) |
Name: |
|
||||||
|
2. |
Reason for the notification |
|||||||
|
a) |
Position/status: |
Executive Chairman & Chief Executive Officer |
||||||
|
b) |
Initial notification/Amendment: |
Initial notification |
||||||
|
3. |
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor |
|||||||
|
a) |
Name: |
Alpha Growth plc |
||||||
|
b) |
LEI: |
213800T46KFT32KYKR91 |
||||||
|
4. |
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted |
|||||||
|
a) |
Description of the financial instrument, type of instrument: Ordinary 0.1p Identification code: GB00BYWKBC49
|
|
||||||
|
b) |
Nature of the transaction: |
Purchase |
||||||
|
c) |
Price(s) and volume(s): |
|
||||||
|
d) |
Aggregated information: Aggregated volume: Price: |
Single transaction as in 4 c) above
|
||||||
|
e) |
Date of the transaction: |
2025-03-31 |
||||||
|
f) |
Place of the transaction: |
London Stock Exchange |
||||||
|
1. |
Details of the person discharging managerial responsibilities/person closely associated |
|||||||
|
a) |
Name: |
|
||||||
|
2. |
Reason for the notification |
|||||||
|
a) |
Position/status: |
Executive Director & Chief Operating Officer |
||||||
|
b) |
Initial notification/Amendment: |
Initial notification |
||||||
|
3. |
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor |
|||||||
|
a) |
Name: |
Alpha Growth plc |
||||||
|
b) |
LEI: |
213800T46KFT32KYKR91 |
||||||
|
4. |
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted |
|||||||
|
a) |
Description of the financial instrument, type of instrument: Ordinary 0.1p Identification code: GB00BYWKBC49
|
|
||||||
|
b) |
Nature of the transaction: |
Purchase |
||||||
|
c) |
Price(s) and volume(s): |
|
||||||
|
d) |
Aggregated information: Aggregated volume: Price: |
Single transaction as in 4 c) above
|
||||||
|
e) |
Date of the transaction: |
2025-03-31 |
||||||
|
f) |
Place of the transaction: |
London Stock Exchange |
||||||
|
Alpha Growth plc |
+44 (0) 20 3959 8600 |
|
|
|
|
Allenby Capital Limited |
+44 (0) 20 3328 5656 |
|
|
|
|
|
|
|
|
About Alpha Growth plc
Specialist in Longevity Assets
Alpha Growth plc is a financial advisory business providing specialist consultancy, advisory, and supplementary services to institutional and qualified investors globally in the multi-billion dollar market of longevity assets and insurance linked asset and wealth management. Building on its well-established network, the Alpha Growth group has a unique position in the insurance and asset services and investment business, as a listed entity with global reach. The group's strategy is to expand its advisory and business services via acquisitions and joint ventures in the
Longevity Assets and Non-correlation
As a longevity asset, it is non-correlated to the real estate, equity capital and commodity markets. Its value is a function of time because as time passes the value gets closer to the face value of the policy. Hence creating a steady increase in the net asset value of the investment. This makes it highly attractive to investors wishing to counteract volatility within an investment portfolio and add yield.
Note: The Company only advises on and manages Longevity Assets that originate in the
***END***
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Proactive Investors is a publisher of financial news and information. No content in this record, or published on the Proactive Investors website (the "Site"), constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is suitable or advisable for any specific person. No content is tailored to any specific person's needs, objectives, or financial situation.
Proactive Investors is not a registered investment adviser or broker-dealer and does not provide personalized investment advice. Nothing in this record constitutes investment advice or a recommendation to buy, hold, or sell any security. None of the information providers or their affiliates will advise you personally concerning the nature, potential, advisability, value, or suitability of any particular security, portfolio, transaction, or investment strategy. Any decision to buy, sell, or hold a security should be made only after consulting an appropriately qualified, licensed financial adviser and reading all relevant offering documentation.
This record, and any record we publish by or on behalf of our clients, should not be construed as an offer or solicitation to buy or sell any product or security. Our content is independent financial journalism, produced in a neutral, objective style with full source attribution.
In accordance with the Federal Trade Commission's guidelines on material connections, Proactive Investors discloses the following: we may receive cash or, in some cases, equity compensation from companies whose news is distributed through our platform. This compensation is for news distribution and media services, not for editorial content or coverage decisions. Where Proactive Investors has a commercial relationship with a company covered in this record, that relationship is disclosed within the article. Any such relationship does not determine, influence, or shape the editorial content produced. Where we receive equity compensation, such securities are held independently by a third-party broker and sold at the broker's discretion.
The Site may contain opinions from time to time regarding securities mentioned in other products, including company-related products, and those opinions may differ from those obtained through another Proactive Investors product. Opinions and commentary reflect the views of the named author at the time of writing and are subject to change without notice.
Price and other data is supplied by sources believed to be reliable. Any calculations are made using such data. Neither the data nor the calculations are guaranteed by those sources, by Proactive Investors, by the information providers, or by any other person or entity, and may not be complete or accurate.
From time to time, reference may be made in our marketing materials to previously published articles or opinions. Such references may be selective, may reference only a portion of an article, and are likely not to be current. As markets change continuously, previously published information and data may not be current and should not be relied upon.
FOR OUR FULL DISCLAIMER CLICK HERE